Receipt of recommended adolescent vaccines among youth with special health care needs

Annie-Laurie McRee; Gary R. Maslow; Paul L. Reiter

doi:10.1177/0009922816661330

Receipt of recommended adolescent vaccines among youth with special health care needs

Annie-Laurie McRee, Gary R. Maslow, Paul L. Reiter

Pediatrics - Adolescent Health and Medicine

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

We examined vaccination coverage among youth with special health care needs (YSHCN) using data from parents of adolescents (11-17 years) who responded to a statewide survey in 2010-2012 (n = 2156). Using a validated screening tool, we identified 29% of adolescents as YSHCN. Weighted multivariable logistic regression assessed associations between special health care needs and receipt of tetanus booster, meningococcal, and human papillomavirus (HPV) vaccines. Only 12% of youth had received all 3 vaccines, with greater coverage for individual vaccines (tetanus booster, 91%; meningococcal, 32%; HPV, 26%). YSHCN had greater odds of HPV vaccination than other youth (33% vs 23%, OR = 1.70, 95% CI = 1.16-2.50) but vaccination coverage was similar (P ≥.05) for other outcomes. In subgroup analyses, HPV vaccination also differed depending on the number and type of special health care needs identified. Findings highlight low levels of vaccination overall and missed opportunities to administer recommended vaccines among all youth, including YSHCN.

Original language	English (US)
Pages (from-to)	451-460
Number of pages	10
Journal	Clinical Pediatrics
Volume	56
Issue number	5
DOIs	https://doi.org/10.1177/0009922816661330
State	Published - May 1 2017

Bibliographical note

Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by grant R40MC28313, MCH Research Program, from the Maternal and Child Health Bureau (Title V, Social Security Act), Health Resources and Services Administration, US Department of Health and Human Services.

Funding Information:
The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: ALM served on the Coalition for Meningococcal B Vaccine for Pfizer, Inc. PLR has received HPV vaccine-related grants from Merck Sharp & Dohme Corp and from Cervical Cancer-Free America whose funding came from an unrestricted educational grant from GlaxoSmithKline. These funds were not used to support this research study. GRM has no disclosures to report.

Publisher Copyright:
© The Author(s) 2016.

Keywords

Adolescent
Health status disparities
Immunization
Special health care needs
Vaccination

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1177/0009922816661330

OpenUrl availability

Full text

Cite this

@article{6d6b5311ce7741a696f5ada579e54ba5,

title = "Receipt of recommended adolescent vaccines among youth with special health care needs",

abstract = "We examined vaccination coverage among youth with special health care needs (YSHCN) using data from parents of adolescents (11-17 years) who responded to a statewide survey in 2010-2012 (n = 2156). Using a validated screening tool, we identified 29% of adolescents as YSHCN. Weighted multivariable logistic regression assessed associations between special health care needs and receipt of tetanus booster, meningococcal, and human papillomavirus (HPV) vaccines. Only 12% of youth had received all 3 vaccines, with greater coverage for individual vaccines (tetanus booster, 91%; meningococcal, 32%; HPV, 26%). YSHCN had greater odds of HPV vaccination than other youth (33% vs 23%, OR = 1.70, 95% CI = 1.16-2.50) but vaccination coverage was similar (P ≥.05) for other outcomes. In subgroup analyses, HPV vaccination also differed depending on the number and type of special health care needs identified. Findings highlight low levels of vaccination overall and missed opportunities to administer recommended vaccines among all youth, including YSHCN.",

keywords = "Adolescent, Health status disparities, Immunization, Special health care needs, Vaccination",

author = "Annie-Laurie McRee and Maslow, {Gary R.} and Reiter, {Paul L.}",

note = "Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by grant R40MC28313, MCH Research Program, from the Maternal and Child Health Bureau (Title V, Social Security Act), Health Resources and Services Administration, US Department of Health and Human Services. Funding Information: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: ALM served on the Coalition for Meningococcal B Vaccine for Pfizer, Inc. PLR has received HPV vaccine-related grants from Merck Sharp & Dohme Corp and from Cervical Cancer-Free America whose funding came from an unrestricted educational grant from GlaxoSmithKline. These funds were not used to support this research study. GRM has no disclosures to report. Publisher Copyright: {\textcopyright} The Author(s) 2016.",

year = "2017",

month = may,

day = "1",

doi = "10.1177/0009922816661330",

language = "English (US)",

volume = "56",

pages = "451--460",

journal = "Clinical Pediatrics",

issn = "0009-9228",

publisher = "SAGE Publications Inc.",

number = "5",

}

TY - JOUR

T1 - Receipt of recommended adolescent vaccines among youth with special health care needs

AU - McRee, Annie-Laurie

AU - Maslow, Gary R.

AU - Reiter, Paul L.

N1 - Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by grant R40MC28313, MCH Research Program, from the Maternal and Child Health Bureau (Title V, Social Security Act), Health Resources and Services Administration, US Department of Health and Human Services. Funding Information: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: ALM served on the Coalition for Meningococcal B Vaccine for Pfizer, Inc. PLR has received HPV vaccine-related grants from Merck Sharp & Dohme Corp and from Cervical Cancer-Free America whose funding came from an unrestricted educational grant from GlaxoSmithKline. These funds were not used to support this research study. GRM has no disclosures to report. Publisher Copyright: © The Author(s) 2016.

PY - 2017/5/1

Y1 - 2017/5/1

N2 - We examined vaccination coverage among youth with special health care needs (YSHCN) using data from parents of adolescents (11-17 years) who responded to a statewide survey in 2010-2012 (n = 2156). Using a validated screening tool, we identified 29% of adolescents as YSHCN. Weighted multivariable logistic regression assessed associations between special health care needs and receipt of tetanus booster, meningococcal, and human papillomavirus (HPV) vaccines. Only 12% of youth had received all 3 vaccines, with greater coverage for individual vaccines (tetanus booster, 91%; meningococcal, 32%; HPV, 26%). YSHCN had greater odds of HPV vaccination than other youth (33% vs 23%, OR = 1.70, 95% CI = 1.16-2.50) but vaccination coverage was similar (P ≥.05) for other outcomes. In subgroup analyses, HPV vaccination also differed depending on the number and type of special health care needs identified. Findings highlight low levels of vaccination overall and missed opportunities to administer recommended vaccines among all youth, including YSHCN.

AB - We examined vaccination coverage among youth with special health care needs (YSHCN) using data from parents of adolescents (11-17 years) who responded to a statewide survey in 2010-2012 (n = 2156). Using a validated screening tool, we identified 29% of adolescents as YSHCN. Weighted multivariable logistic regression assessed associations between special health care needs and receipt of tetanus booster, meningococcal, and human papillomavirus (HPV) vaccines. Only 12% of youth had received all 3 vaccines, with greater coverage for individual vaccines (tetanus booster, 91%; meningococcal, 32%; HPV, 26%). YSHCN had greater odds of HPV vaccination than other youth (33% vs 23%, OR = 1.70, 95% CI = 1.16-2.50) but vaccination coverage was similar (P ≥.05) for other outcomes. In subgroup analyses, HPV vaccination also differed depending on the number and type of special health care needs identified. Findings highlight low levels of vaccination overall and missed opportunities to administer recommended vaccines among all youth, including YSHCN.

KW - Adolescent

KW - Health status disparities

KW - Immunization

KW - Special health care needs

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=85021858856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021858856&partnerID=8YFLogxK

U2 - 10.1177/0009922816661330

DO - 10.1177/0009922816661330

M3 - Article

C2 - 27470263

AN - SCOPUS:85021858856

SN - 0009-9228

VL - 56

SP - 451

EP - 460

JO - Clinical Pediatrics

JF - Clinical Pediatrics

IS - 5

ER -

Receipt of recommended adolescent vaccines among youth with special health care needs

Abstract

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this